The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study
Introduction. In the United States, dietary supplement (DS) use is common, often takes place outside of the purview of health care providers, and may involve DS in combination with pharmaceuticals. This situation has led to concerns about interactions between DS and pharmaceuticals, as well as the r...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/823853 |
id |
doaj-fd6bfd51a1da41e3a9f603387706e5a8 |
---|---|
record_format |
Article |
spelling |
doaj-fd6bfd51a1da41e3a9f603387706e5a82020-11-25T00:32:14ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882014-01-01201410.1155/2014/823853823853The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National StudyDavid S. Kiefer0Joe C. Chase1Gayle D. Love2Bruce P. Barrett3Department of Family Medicine, University of Wisconsin, 1100 Delaplaine Court, Madison, WI 53715, USADepartment of Family Medicine, University of Wisconsin, 1100 Delaplaine Court, Madison, WI 53715, USAInstitute on Aging, University of Wisconsin, 1100 Delaplaine Court, Madison, WI 53715, USADepartment of Family Medicine, University of Wisconsin, 1100 Delaplaine Court, Madison, WI 53715, USAIntroduction. In the United States, dietary supplement (DS) use is common, often takes place outside of the purview of health care providers, and may involve DS in combination with pharmaceuticals. This situation has led to concerns about interactions between DS and pharmaceuticals, as well as the risks from polypharmacy and polysupplement use. Methods. We used data from the Midlife in the US study (MIDUS 2 Survey) to examine DS and prescription pharmaceutical use in 3876 study participants in order to determine the demographics of high-users (5 or more) of DS and pharmaceuticals and the presence of DS-pharmaceutical co-use. Results. Over 69% of study participants regularly used DS, 49.6% regularly used both DS and pharmaceuticals, and 6.3% and 8.7% were high-users of pharmaceuticals and DS, respectively. High-users of DS, pharmaceuticals, and either were more likely than the whole cohort to be female and of lower income. Conclusions. These findings corroborate those of other national studies with respect to the demographics of DS users but add new information about people at risk of DS-pharmaceutical interactions, not an insignificant proportion of the population examined by this dataset.http://dx.doi.org/10.1155/2014/823853 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
David S. Kiefer Joe C. Chase Gayle D. Love Bruce P. Barrett |
spellingShingle |
David S. Kiefer Joe C. Chase Gayle D. Love Bruce P. Barrett The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study Evidence-Based Complementary and Alternative Medicine |
author_facet |
David S. Kiefer Joe C. Chase Gayle D. Love Bruce P. Barrett |
author_sort |
David S. Kiefer |
title |
The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study |
title_short |
The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study |
title_full |
The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study |
title_fullStr |
The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study |
title_full_unstemmed |
The Overlap of Dietary Supplement and Pharmaceutical Use in the MIDUS National Study |
title_sort |
overlap of dietary supplement and pharmaceutical use in the midus national study |
publisher |
Hindawi Limited |
series |
Evidence-Based Complementary and Alternative Medicine |
issn |
1741-427X 1741-4288 |
publishDate |
2014-01-01 |
description |
Introduction. In the United States, dietary supplement (DS) use is common, often takes place outside of the purview of health care providers, and may involve DS in combination with pharmaceuticals. This situation has led to concerns about interactions between DS and pharmaceuticals, as well as the risks from polypharmacy and polysupplement use. Methods. We used data from the Midlife in the US study (MIDUS 2 Survey) to examine DS and prescription pharmaceutical use in 3876 study participants in order to determine the demographics of high-users (5 or more) of DS and pharmaceuticals and the presence of DS-pharmaceutical co-use. Results. Over 69% of study participants regularly used DS, 49.6% regularly used both DS and pharmaceuticals, and 6.3% and 8.7% were high-users of pharmaceuticals and DS, respectively. High-users of DS, pharmaceuticals, and either were more likely than the whole cohort to be female and of lower income. Conclusions. These findings corroborate those of other national studies with respect to the demographics of DS users but add new information about people at risk of DS-pharmaceutical interactions, not an insignificant proportion of the population examined by this dataset. |
url |
http://dx.doi.org/10.1155/2014/823853 |
work_keys_str_mv |
AT davidskiefer theoverlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT joecchase theoverlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT gayledlove theoverlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT brucepbarrett theoverlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT davidskiefer overlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT joecchase overlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT gayledlove overlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy AT brucepbarrett overlapofdietarysupplementandpharmaceuticaluseinthemidusnationalstudy |
_version_ |
1725320200646033408 |